Comparison of Efficacy and Safety Profiles Between Omadacycline and Moxifloxacin in Elderly Patients with Community‐Acquired Pneumonia: A Randomized, Controlled Trial

Clinical Pharmacology in Drug Development · Published 2025-11-21 · DOI 10.1002/cpdd.1627

Authors being retrieved — see the publisher record. https://doi.org/10.1002/cpdd.1627

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Efficacy and safety of Omadacycline in community-acquired pneumonia among elderly patients: a real-world evidence study · Frontiers in Cellular and Infection Microbiology · 2026 · Cites or is cited by this article
• Thorough QT Study on the Effect of Therapeutic and Supratherapeutic Dosing of Givinostat in Healthy Volunteers · Clinical Pharmacology in Drug Development · 2026 · Same journal
• Distributed Manufacturing, Foreign Establishments, and Why the FDA's New Proposed Rule Matters to Clinical Pharmacology · Clinical Pharmacology in Drug Development · 2026 · Same journal
• Pharmacokinetics, Bioequivalence, and Safety Evaluation of Two Voriconazole Tablets in Healthy Chinese Volunteers · Clinical Pharmacology in Drug Development · 2026 · Same journal
• Pharmacokinetics and Bioequivalence of Tamsulosin Hydrochloride Extended‐Release Capsules in Healthy Chinese Volunteers: A Randomized, Open‐Label, Crossover Study Under Fasting and Fed Conditions · Clinical Pharmacology in Drug Development · 2026 · Same journal
• Pharmacokinetic Interaction Between Atorvastatin and Hybutimibe in Healthy Chinese Volunteers · Clinical Pharmacology in Drug Development · 2026 · Same journal
• Single‐Dose Pharmacokinetic Assessment of TNX‐102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open‐Label Studies in Healthy Volunteers · Clinical Pharmacology in Drug Development · 2026 · Same journal
• From Reflection to Acceleration: Clinical Pharmacology’s 2025 Lessons and 2026 Opportunities · Clinical Pharmacology in Drug Development · 2026 · Same journal
• Pharmacokinetic Comparability of ABP 654, a Biosimilar to Ustekinumab, Administered Either via Prefilled Syringe or Autoinjector in Healthy Adults: Results from a Randomized, Open‐Label, Parallel‐Group Study · Clinical Pharmacology in Drug Development · 2026 · Same journal
• Pharmacokinetics and Safety of VV116 in Subjects With Mild or Moderate Hepatic Impairment Compared With Healthy Controls: A Phase I, Open‐Label Study · Clinical Pharmacology in Drug Development · 2026 · Same journal